Andrew X. Zhu, Md, Phd, On Ivosidenib As A 1st Line Therapy For Patients With Cca & An Idh1 Mutation

2022 1:44
Synopsis
Dr. Zhu, Director Emeritus, Liver Cancer Research, Mass General Hospital Cancer Center, Director, Jiahui International Cancer ...

You Might Also Like

Andrew X. Zhu, MD, PhD, discusses the final results of the ClarIDHy trial from ASCO GI 2021 4:42
Andrew X. Zhu, Md, Phd, Discusses The Final Results Of The C...
2022
Andrew X. Zhu, MD, PhD, speculates on the potential impact of the ClarIDHy trial 2:03
Andrew X. Zhu, Md, Phd, Speculates On The Potential Impact O...
2022
Andrew X. Zhu, MD, PhD, elaborates on the role of genetic testing in cholangiocarcinoma 2:00
Andrew X. Zhu, Md, Phd, Elaborates On The Role Of Genetic Te...
2022
Andrew X. Zhu, MD, PhD, regarding checkpoint inhibitors in advanced HCC 1:21
Andrew X. Zhu, Md, Phd, Regarding Checkpoint Inhibitors In A...
2020
Andrew X. Zhu, MD, PhD, on what physicians should know about sequencing TKIs in HCC 1:23
Andrew X. Zhu, Md, Phd, On What Physicians Should Know About...
2020
Andrew X. Zhu, MD, PhD, considers whether sorafenib is tolerable in combination with I-O in HCC 1:01
Andrew X. Zhu, Md, Phd, Considers Whether Sorafenib Is Toler...
2020
Ivosidenib for Advanced IDH1-Mutated CCA 6:53
Ivosidenib For Advanced Idh1-mutated Cca
2020
ClarIDHy: ivosidenib in CCA 1:29
Claridhy: Ivosidenib In Cca
2021
Final results from ClarIDHy: ivosidenib in IDH1-mutated CCA 2:42
Final Results From Claridhy: Ivosidenib In Idh1-mutated Cca
2022
Andrew Zhu, MD, PhD, shares thoughts on treating adjuvant hepatocellular carcinoma (HCC) today 1:01
Andrew Zhu, Md, Phd, Shares Thoughts On Treating Adjuvant He...
2019
ClarIDHy: updates and initial findings for ivosidenib in CCA 2:29
Claridhy: Updates And Initial Findings For Ivosidenib In Cca
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.